Nitric oxide and molsidomine in the management of pulmonary hypertension in Takayasu's arteritis.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 11157624.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We present three patients with pulmonary hypertension in Takayasu's arteritis who showed long-term favorable response, clinically and hemodynamically, to nitric oxide donor molsidomine. In these patients, nitric oxide inhalation was effective in reducing pulmonary artery pressure (PAP) and pulmonary vascular resistance (PVR). Molsidomine (single dose of 4 mg p.o.) was also effective in reducing PAP and PVR, but nifedipine was not. With molsidomine, 4 mg tid, dyspnea, exercise capacity, and hemodynamic parameters were improved. These favorable responses have lasted during the 3-month follow-up period in all patients.
Medical subject headings
- Hypertension, Pulmonary
- Molsidomine
- Nitric Oxide Donors
- Takayasu Arteritis